Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 119
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Kristen Nash and Erica Siegel on Risk Reduction and Psychedelic Safety
Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study
Pα+ Psychedelic Bulletin #203: Norway Considers Funding Off-Label Ketamine for TRD; Longevity Crowd Hypes Psilocybin Study; Will State-Legal Psychedelics Eat Psychedelic Pharma’s Lunch?
Psychedelic Funding Update: Q2 2025
Daniel Pinchbeck – From Cultural Catalyst to Capitalist Co-option: Reflections on Psychedelic Science, AI, and Idealist Monism
FILAMENT HEALTH ANNOUNCES PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION...
PT374 – Personalizing Psychedelic Integration
Psychedelic Brains In A Dish
Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting...
Psychedelic Bulletin #124: MAPS Wraps Second Phase 3 MDMA Trial; Preparing...
Why Did Psychedelics Relieve My Chronic Pain?
Psychedelics Weekly – Oregon Measure 109: Approaching the Proposed Final Rules
MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD
Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of...
Surprising Results: Psilocybin Trial for Depression Alleviates Chronic Pain
1
...
118
119
120
...
292
Page 119 of 292
